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Beside the classical flat parietal epithelial cells (PECs), we
investigated proximal tubular epithelial-like cells, a
neglected subgroup of PECs. These cells, termed cuboidal
PECs, make up the most proximal part of the proximal
tubule and may also line parts of Bowman’s capsule.
Additionally, a third intermediate PEC subgroup was
identified at the junction between the flat and cuboidal PEC
subgroups at the tubular orifice. The transgenic mouse line
PEC-rtTA labeled all three PEC subgroups. Here we show
that the inducible Pax8-rtTA mouse line specifically labeled
only cuboidal and intermediate PECs, but not flat PECs. In
aging Pax8-rtTA mice, cell fate mapping showed no
evidence for significant transdifferentiation from flat PECs
to cuboidal or intermediate PECs or vice versa. In murine
glomerular disease models of crescentic
glomerulonephritis, and focal segmental
glomerulosclerosis (FSGS), intermediate PECs became more
numerous. These intermediate PECs preferentially
expressed activation markers CD44 and Ki-67, suggesting
that this subgroup of PECs was activated more easily than
the classical flat PECs. In mice with FSGS, cuboidal and
intermediate PECs formed sclerotic lesions. In patients with
FSGS, cells forming the tip lesions expressed markers of
intermediate PECs. These novel PEC subgroups form
sclerotic lesions and were more prone to cellular activation
compared to the classical flat PECs in disease. Thus,
colonization of Bowman’s capsule by cuboidal PECs may
predispose to lesion formation and chronic kidney disease.
We propose that tip lesions originate from this novel
subgroup of PECs in patients with FSGS.
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W ithin the glomerulus, classical PECs are flat cells thatreside on Bowman’s capsule. Recent evidence sug-gests that PECs are main effectors in the develop-
ment of glomerulosclerotic as well as of proliferative lesions.3–7
PECs can undergo cellular activation, leading to increased
capacity to proliferate, migrate, and produce extracellular
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Translational Statement
Here we show by genetic cell–fate tracing that glomer-
ular epithelial lesions can be formed not only by the
classical flat PECs, but also by another subgroup of PECs
derived from proximal tubule-like cells. At the junction
to flat PECs, proximal tubule-like cells (termed interme-
diate PECs) transition into a phenotype termed scattered
tubular cell (STC) phenotype. In glomerular diseases such
as primary FSGS, the intermediate PECs near the
glomerular tuft become more numerous, proliferate
sooner than classical flat PECs, and form early lesions
preferentially. These findings may help to understand
the pathogenesis of the different patterns of glomerular
lesions, in particular the tip lesion.
Glomerular injury and subsequent FSGS account for
the great majority of diseases that progress to end-stage
kidney disease.1,2
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matrix. De novo expression of CD44 is an established marker
for PEC activation,4,8,9 and modulation of CD44 signaling
attenuates the development of glomerulosclerotic lesions.10,11
In FSGS, activated PECs and podocytes form cellular adhe-
sions (synechiae) between Bowman’s capsule and the
glomerular tuft.12 Via this process, they are the earliest
defining lesions for subsequent development of sclerotic le-
sions and FSGS.13–16 For this reason, PEC activation has
become a new potential therapeutic target in glomerular
diseases.
Importantly, PEC activation is also relevant as a diagnostic
tool. Markers of PEC activation have already been used in hu-
man biopsies to differentiate diseases without glomerulo-
sclerosis, such asminimal change disease, from primary FSGS.17
Importantly for this study, PECs show a similar expression
pattern as do proximal tubular cells, which have transiently
acquired the STC phenotype.18 The STC phenotype is a
specific transcriptional program. It designates a common
response pattern of proximal tubular cells to injury. Proximal
tubule cells in the STC phenotype have less brush border and
mitochondria particularly in humans, express specific
markers de novo (e.g., CD44),19 and proliferate more, pre-
sumably to aid tubular regeneration.18,20
In this study, we show for the first time an unex-
pected role of the most proximal tubular cells in the
development of early FSGS lesions in animal models and
patients.
RESULTS
PEC subgroups on Bowman’s capsule
When staining for STC markers on human kidney sections
(described elsewhere7,19,21), individual cells coexpressing STC
markers keratin 7 and 19 (K7, K19), G protein-coupled bile
acid receptor 1, and hepatocyte nuclear factor-4 were regu-
larly observed at the tubular orifice. Remarkably, this cell was
located between the classical flat PECs and the proximal
tubular cells (Figure 1a-c arrowheads; Supplementary
Figure S1A–C). This cell was termed intermediate PEC
(iPEC).
In a minority of glomeruli, proximal tubule-like cells
extended from the tubular outlet onto Bowman’s capsule
(Figure 1d–h, arrows). By definition, cells located on
Bowman’s capsule are termed PECs.22–25 Thus, the
proximal tubule-like cells extending onto Bowman’s
capsule were termed cuboidal PECs. In about one-half of
the cases, cuboidal PECs were stained with lotus tetra-
gonolobus agglutinin (LTA), indicating that they may
retain their brush border in humans. In these glomeruli,
the iPEC expressing STC markers was again present next
to the classical flat PECs (Figure 1d–g, arrowheads). As
shown in Supplementary Figure S2, glycosylated CD133
and CD24 were expressed on all flat PECs in normal
human kidney. Expression was similar on all cells and
there was an abrupt transition from podocalyxin-positive
(podocytes) to glycosylated CD133 and CD24–positive
flat PECs.
By transmission electron-microscopy, intermediate PECs
were triangular in shape with a lighter cytoplasm (less ribo-
somes) and no brush border (Figure 1h, arrowheads).
PEC subpopulations in mice
In healthy mice, flat PECs extended from the vascular pole
along Bowman’s capsule and were stained specifically for src-
suppressed C-kinase (SSeCKS) (Figure 1i and j,
Supplementary Figure S3A).26 Cuboidal PECs with a larger
cytoplasm and cuboidal shape extended from the tubular pole
(Figure 1i, arrows) and stained for the brush border marker
LTA (Figure 1j).
Significantly more cuboidal PECs were present on Bow-
man’s capsule in male versus female mice (Figure 1k), as
reported previously.25,27 On random biopsies of human tu-
mor nephrectomies (n ¼ 10, 40–50 glomerular cross sec-
tions each), a similar trend was noticed but did not reach
significance (Figure 1g). Ultrastructurally, flat PECs were 100
to 500 nm in height (comparable to primary podocyte foot
processes), with an oval-shaped nucleus (1–2 mm in height)
with condensed chromatin and an electron-lucent cytoplasm
(Supplementary Figure S3B). Flat PECs had no brush border
and a low number of resorption vacuoles and mitochondria.
At the interface between flat and cuboidal PECs, interme-
diate PECs were regularly detected (Figure 1h and l,
arrowheads).
In mice, STC marker cyclin D1 (CKD1) was expressed
specifically in iPECs and in a graded fashion also in cuboidal
PECs in normal mouse kidneys (Figure 2a and b). A sche-
matic and summary of the marker expression profile on the
PEC subgroups is shown in the next section.
Genetic labeling of PEC subpopulations in mice
To clarify the role of PEC subpopulations in vivo, we found
that cuboidal and iPECs could be labeled specifically in
quadruple transgenic Pax8-rtTA/LC1/R26R/hist-GFP reporter
mice (Figure 2c–d000). On administration of doxycycline
(dox), renal epithelial cells were labeled except for flat PECs
or podocytes. Two reporter systems were used that comple-
ment each other: LC1/R26R activated cytoplasmic expression
of b-galactosidase (b-Gal) irreversibly (Figure 2c). As second
reporter, the nucleus was loaded with green fluorescent pro-
tein histone (hist-GFP) resulting in reversible metabolic la-
beling (Figure 2c). SSeCKSLTAþ cuboidal PECs and
SSeCKSþLTA iPECs were marked by Pax8-rtTA mice
(Figure 2d-f). SSeCKSþLTA flat PECs were not labeled,
allowing us to identify and trace the new PEC subpopulations
in mice. Next, the previously described quadruple-transgenic
PEC-rtTA mouse was analyzed (the “parietal cell mouse”)
(Figure 2g).28 As shown in Figure 2h, this transgenic line
labeled all 3 PEC subgroups: flat SSeCKS PECs (arrows),
LTAþ cPECs (arrowheads), and the iPECs in between (arrows
with dots). Of note, transgenic labeling extended several cells
into the proximal tubule, suggesting that these cells are
different from other proximal tubular cells (Figure 2h [right
angles] and i [arrows]).
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Figure 1 | Parietal epithelial cell (PEC) subpopulations in humans and mice. (a–e) Immunofluorescence stainings of normal human kidney
shows co-expression of keratin 7 (K7), K19, and G protein–coupled bile acid receptor 1 (TGR5) in intermediate PECs at the tubular (tub.) orifice
(arrowheads) and within cells of the proximal (scattered tubular cells, arrows with tails) and distal tubule (right angles). *Podocytes (a,h). As shown in
the examples (c) to (e), lotus tetragonolobus agglutinin (LTA)þ proximal tubular-like cells may extend onto Bowman’s capsule (BC; cuboidal PECs,
long thin arrows). Bars ¼ 100 mm. (f–h) Cuboidal PECs with brush border in human biopsy kidney section (arrows). In addition, (continued)
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PEC subpopulations in aging
To test whether iPECs or cuboidal PECs or both are regen-
erated by flat PECs or vice versa, Pax8-rtTA mice received dox
at 5 weeks of age. Transgenic labeling of intermediate and
cuboidal PECs was verified at 3 months of age, where virtually
all LTAþ cuboidal PECs were irreversibly b-Galþ (Figure 3a).
In 12-month-old mice, the pattern of genetic labeling with
the irreversible marker b-Gal was unchanged; that is, cuboidal
PECs did not lose the genetic label and flat PECs did not
acquire it (Figure 3a and b). These results do not support
significant transdifferentiation or regeneration among the
PEC subgroups in aging mice. Of note, a differential retention
of the metabolic nuclear hist-GFP was observed in the aging
experiments. Immediately after labeling, more than 90% of
the intermediate and cuboidal PECs were labeled. Over time,
hist-GFP was lost in cuboidal PECs and proximal tubule cells
due to physiological turnover of the cells or only the histones
in these cells. In contrast, hist-GFP was preserved in 80% and
50% of the nuclei of iPECs at 6 and 12 months of age,
respectively (Figure 3c and d). To verify this finding, the same
pulse chase experiment was performed using the PEC-rtTA
transgenic mouse. Three months after labeling PECs,
histone-eGFP was retained in 80% of iPECs, confirming our
findings in Pax8-rtTA mice (Supplementary Figure S4). In
contrast, histone-eGFP was lost in flat and cuboidal PECs and
most other tubular cells. In summary, the unique long half-
life of histones and marker expression in iPECs suggested
that these cells may have distinct cellular properties.
Differential cellular activation of PEC subpopulations
PECs become activated in FSGS, as well as in rapidly pro-
gressive glomerulonephritis.3,4 De novo expression of activa-
tion marker CD44 was observed preferentially in iPECs
within the glomeruli, which were not affected by lesions, in
mice with FSGS and rapidly progressive glomerulonephritis
(representative images in Figure 3e and Supplementary
Figure S4C for FSGS, and Figure 3f–f00 for rapidly progres-
sive glomerulonephritis). For a statistical analysis, the Thy1.1
mouse model for FSGS was analyzed at a time point prior to
lesion formation (Figure 3g–j). In this model, FSGS with
prominent PEC activation can be induced by a single injec-
tion of a cytotoxic antibody to transgenic Thy1.1 expressed on
podocytes.4,29,30 Four days after induction, a higher percent-
age of cuboidal PECs expressed CD44, suggesting that these
cells are more prone to activation than flat PECs (Figure 3h
and i). Proliferation was highest in iPECs (90% positive),
decreasing in the neighboring cuboidal PECs, and was not
increased significantly in proximal tubular epithelial cells
(Figure 3j).
Origin of cellular adhesions/synechiae in FSGS
As shown in Figure 4a, as the first defining lesion for FSGS, an
adhesion is formed preferentially between flat and cuboidal
PECs on Bowman’s capsule and the glomerular tuft, where
iPECs are localized.31 To explore this further, FSGS was
induced in transgenic Pax8-rtTA mice using the 5/6 ne-
phrectomy and deoxycorticosterone acetate–salt model
(Figure 4b). FSGS lesions contained enhanced green fluo-
rescent protein (EGFP)þ intermediate or cuboidal PECs or
both, suggesting that these PEC populations participate in the
formation of sclerotic lesions (Figure 4c and d). The contri-
bution of labeled PECs was higher in male versus female
animals (i.e., 75% vs. 50%, respectively). Proliferative lesions
(i.e., extracapillary proliferations, cellular crescents) con-
tained almost exclusively intermediate or cuboidal PECs or
both (Figure 4c, right panel). These findings were corrobo-
rated by the second irreversible reporter transgene b-Gal
(Figure 4e).
As shown in Figure 4f and g, genetically marked PECs
expressing SSeCKS became more numerous—potentially by
cellular proliferation (Figure 4f, right panel). In addition, it is
also possible that cuboidal PECs transitioned into the iPEC
phenotype on injury or activation or both, analogous to any
proximal tubular cell. As shown in Figure 4h, genetically
irreversibly marked cuboidal PECs expressing b-Gal have lost
their brush border (LTA staining) in this FSGS model, sug-
gesting that they have transitioned at least in part into the
STC phenotype to become iPECs.
Genetically marked cells can only be counted with cer-
tainty using nuclear markers, such as histone-eGFP. However,
significant loss of the metabolic labeling with histone-eGFP
was observed in LTAþ cuboidal PECs and proximal tubular
cells in our FSGS model (Figure 4c and f, arrows with tails),
which was not observed using the irreversible reporter b-Gal
(Figure 4e). Therefore the contribution of cuboidal PECs to
lesion formation was underestimated in Figure. 4d using
EGFP as marker in this study and may be even higher.
Intermediate PECs as potential origin of the tip-lesion
According to the Columbia classification,32 the tip variant is a
unique lesion where an adhesion is formed in early FSGS
close to the tubular outlet where iPECs are located and that is
=
Figure 1 | (continued) intermediate PECs (arrowheads) between flat and cuboidal PECs (semithin section). Bar ¼ 50 mm. (g) Quantification
of cuboidal PECs in tumor nephrectomies of human male and female subjects (1 dot equals mean of 40–50 glomeruli per patient, n ¼ 10 each,
unpaired t-test; not significant [n.s.]). (h) Transmission electron microscopy (TEM) showing intermediate PECs (arrowheads) and cuboidal PECs
on Bowman’s capsule in human kidney. Bar ¼ 1 mm. (i–l) PEC subpopulations in healthy mice. (i) Periodic acid–Schiff (PAS)–staining.
Bar ¼ 50 mm. (j) Immunofluorescent staining for src-suppressed C-kinase (SSeCKS; flat PECs, arrowheads), LTA (brush border of cuboidal PECs,
arrows), and synaptopodin (*podocytes). (k) Quantification of glomerular cross sections with LTAþ cells on Bowman’s capsule
(****P < 0.0001, n ¼ 10 mice/sex, 25 glomerular cross sections per mouse). (l) TEM of Bowman’s capsule in mice. PECs show brush border at the
apical membrane (arrows with tails). Another population shows an intermediate cell phenotype with an absent brush border and reduced
amount of mitochondria (arrowheads). Bar ¼ 1000 nm. DAPI, 40,6-diamidino-2-phenylindole. To optimize viewing of this image, please see the
online version of this article at www.kidney-international.org.
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Figure 2 | Markers for intermediate parietal epithelial cells (iPECs) in mice (a,b) and lineage tracing and immunolabeling of PEC
populations (d–i). (a) Distribution of cyclin D1þ cells on Bowman’s capsule in wild-type mice. (Immunofluorescent staining for cyclin D1, red
and lotus tetragonolobus agglutinin [LTA], green.) Note that cyclin D1 showed the highest expression level in presumptive iPECs between
flat PECs (fPECs) and cuboidal PECs (cPECs). (b) Analysis of distribution of cyclin D1 on Bowman’s capsule (n ¼ 10; shown are the mean and SDs,
analysis of variance; *P < 0.1, **P < 0.01). (c–i) Pax8-rtTA transgenic reporter mice label cuboidal and intermediate PECs on Bowman’s capsule.
(c) Transgenic map of Pax8-rtTA mice. (d) Quadruple immunofluorescent staining (continued)
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prone to cellular activation. To test whether iPECs can be
detected in tip lesions, human renal biopsies of early FSGS
recurrences after renal transplantation showing a high fre-
quency of tip lesions were investigated. Tip lesions were
identified on periodic acid–Schiff (PAS)–stained serial sec-
tions (Figure 5a). Cells in tip lesions stained positively for the
iPEC marker K7.
In a systematic analysis of 23 human biopsies diagnosed
with FSGS tip lesions, FSGS lesions were visualized based on
the global PEC marker annexin A3 as described previously.12
Glomerulosclerotic lesions were classified into 3 groups: (i)
tip variant, (ii) adhesion, that is, a synechia between the tuft
and capsule away from the tubular orifice; and (iii) not
otherwise specified lesion (i.e., several adhesions or advanced
annexin A3þ lesions as defined in Howie et al.14). While 90%
of tip lesions showed K7 expression, only 42% of other ad-
hesions and 32% of not otherwise specified lesions expressed
K7 (Figure 5b and c, Supplementary Figure S5). In summary,
tip lesions contained the highest number of cells expressing
K7 in human FSGS. This is in line with the notion that iPECs
located at the tubular orifice may be the first cells to form a
cellular adhesion in this situation.
DISCUSSION
In the present study, we examined the potential relevance of 2
novel PEC subgroups (cuboidal and intermediate PECs). The
cuboidal PECs at the junction to the classical flat PECs
expressed STC markers, and these cells were also more prone
to cellular activation and proliferation similar to proximal
tubule cells, which have transitioned into the STC phenotype
after injury (Figure 6). The results suggest that the epithelial
interface between flat PECs and cuboidal PECs on Bowman’s
capsule represents a potential hot spot for FSGS lesion
formation.
Our first major finding is that we have identified specific
markers (see Figure 7 for a summary of the markers) and
transgenic mouse lines that allow us to differentiate 3 PEC
subgroups. Previously, cuboidal PECs have been reported
based on their morphology in mice, rats, humans, dogs, cats,
and cows.27,33–35 Cuboidal PECs express markers of proximal
tubular cells (e.g., the transporters Slc5a2 and Slc7a13);
however, their morphology and transcriptome is not identical
to those of proximal tubule cells.22,36 In a single-cell tran-
scriptomic analysis, this subgroup clustered into a distinct
group of PECs rather than proximal tubule cells.37 This is
supported by our observation that the PEC-specific transgenic
mouse line PEC-rtTA labels intermediate and cuboidal PECs,
but not proximal tubule cells, consistent with the notion that
these cell populations are not identical. Intermediate PECs
have been reported in various mammals based on their
morphology (i.e., triangular shape), absence of apical
microvilli, and low number of mitochondria.22–24 Sex hor-
mones25,27 and age22 have been described to modify the
phenotype of the parietal epithelium, otherwise little was
known so far about their potential relevance.
Low-level cellular proliferation within flat PECs has been
described.38 Consistent with that, we found no evidence for
transdifferentiation of flat PECs into cuboidal PECs or vice
versa. Previous studies have proposed a potential progenitor
cell population of glycosylated CD133 and CD24–positive
adult parietal epithelial multipotent progenitors in humans at
this site.39,40 Our findings are consistent with our previous
cell fate tracing experiments in adult aging mice where no
significant replenishment of other epithelial cells from PECs
was observed.41,42
In our second major finding, cuboidal PECs may tran-
sition into the iPEC phenotype in glomerular disease
models. The markers for injured proximal tubular cells,
which have transitioned into the transient STC phenotype
are also expressed by the iPEC phenotype.18,19,21 Compared
with neighboring proximal tubule cells, which have not
transitioned into the STC phenotype, STCs lose their brush
border, contain fewer mitochondria, express markers of
cellular activation, and proliferate earlier and more. For
these reasons, the STC phenotype was interpreted as a
transient regenerative response pattern of the proximal tu-
bule after injury, which is beneficial for regeneration of the
tubule.18–20 Our findings indicate that the regenerative STC
phenotype is activated also in cuboidal PECs, which are
derived from proximal tubule cells, causing a phenotypic
transition of these cells into iPECs. Intermediate PECs
showed similarities with STCs, for example, similar marker
expression and higher proliferation. Two iPEC markers
were identified in this study, SSeCKS and cyclin D1, which
have been shown to interact with each other to regulate
cellular proliferation in cultured PECs.26 Furthermore,
SSeCKS knockout mice formed significantly more flat PECs
and developed more cellular lesions in glomerular disease,26
suggesting that cells in the iPEC phenotype have an altered
proliferation.
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Figure 2 | (continued) (src-suppressed C-kinase [SSeCKS], enhanced green fluorescent protein [EGFP], LTA, and 40,6-diamidino-2-phenylindole
[DAPI]) in Pax8-rtTA mice shows no labeling with EGFP in fPECs (arrowheads), whereas cPECs stained positive (pos) for EGFP. Note that
SSeCKS marks fPECs and iPECs are marked by both EGFP and SSeCKS (arrows with tails). Bars ¼ 75 mm (a,d). (e) Co-staining of histone-eGFP and
X-gal staining. EGFP (arrowheads) staining was only positive in ß-Galþ cPECs (arrows). Bars ¼ 100 mm. (f) Schematic of the labeling pattern in
Pax8-rtTA quadruple transgenic mice. (g) Transgenic map of the PEC-rtTA mouse. (h) It labels SSeCKSþ fPECs (arrows), iPECs (arrows with
circles), and LTAþ cPECs (arrowheads) including the proximal part of the proximal tubule (right angles). Intermediate PECs are highlighted in
the inset; note that SSeCKS staining is on both sides of the green nucleus (arrows). As described previously, proximal tubular cells in the
scattered tubular cell phenotype (LTA-negative) are labeled by the PEC-rtTA mouse as well (arrow with tails). Bars ¼ 50 mm.
(i) Labeling of the proximal part of the proximal tubule by the PEC-rtTA mouse visualized by the irreversible reporter b-galactosidase (b-Gal)
(arrows). Bar ¼ 50 mm. cytopl, cytoplasmic; dox, doxycycline; neg, negative; prom, promoter. To optimize viewing of this image, please see the
online version of this article at www.kidney-international.org.
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Figure 3 | Lineage tracing of Pax8-rtTA mice (a–d) and preferential activation of intermediate parietal epithelial cells (iPECs)
and cuboidal PECs (e–j). (a) Lotus tetragonolobus agglutinin (LTA)þ PECs were nearly always positive (pos) for b-galactosidase
(ß-gal) at 3 months of age. (b) Co-staining of ß-gal and LTA in PAX8-rtTA mice at 12 months of age shows co-expression of both markers
(arrows). Bars ¼ 100 mm. (c,d) Analysis of enhanced green fluorescent protein (EGFP) in kidneys of aged Pax8-rtTA mice. PECs
located between flat PECs and cuboidal PECs showed preferentially a positive staining for EGFP (arrows). Bar ¼ 50 mm. (d) Analysis of
distribution of EGFP signal on Bowman’s capsule. n ¼ 5 per time point. (e) CD44 immunostaining of kidneys of mice subjected to 5/6
nephrectomy (Nx) þ deoxycorticosterone acetate (DOCA)–salt treatment as outlined in Figure 4b and (f) of mice treated with
nephrotoxic nephritis serum to induce crescentic glomerulonephritis for 8 days. In sporadic glomeruli without lesions, CD44 was positive on
Bowman’s capsule in a subset of iPECs (arrowheads) preferentially at the interface between flat PECs and cuboidal PECs (arrows
in f,h). Bars ¼ 100 mm (e,f) and 50 mm (f0,f0 0). (g) Schematic summary of the Thy1.1 focal segmental glomerulosclerosis (FSGS) mouse
model, which expresses the Thy1.1 antigen in podocytes. Acute podocyte injury and FSGS can be induced after injection of Thy1
antibody (ab) 19XE5. (h) Exemplary immunofluorescence staining of Ki-67 and LTA 4 days after induction of FSGS demonstrates preferential
expression of proliferation marker Ki-67 in iPECs (arrowhead). Bar ¼ 50 mm. (i) Analysis of de novo expression of CD44 in
LTA-negative (neg) versus LTAþ PECs (i.e., flat vs. cuboidal PECs, respectively) in Thy1.1 mice (n ¼ 4; 50 glomerular cross (continued)
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The third major finding of this study was that proximal
tubule cells (i.e., intermediate and cuboidal PECs) participate
in glomerular lesion formation. Beside flat PECs and podo-
cytes, this adds an unexpected third epithelial cell type, which
may form glomerular sclerotic lesions. We found that the
novel subgroup of PECs is activated sooner and proliferates
more than the classical flat PECs in glomerular disease. It
should be noted that flat PECs participate in lesion formation
as well. Our preliminary results suggest that flat PECs form
lesions somewhat later if the initiating glomerular diseases
persist.
The cellular mechanism for the unusual retention of
histones in iPECs in normal mice remains unclear. It could
suggest a lower cellular turnover or more likely a lower
turnover of the histones within the nuclei of iPECs. In any
case, the finding indicates that the iPEC phenotype is stable
over a longer period of time. Some kind of persistent stress
or force might be the reason for the STC phenotype in the
cell at the junction between flat and larger cuboidal PECs. In
other tissues, interfaces between different epithelia show
increased susceptibility to pathology, such as interfaces be-
tween squamous and cuboidal epithelia, such as the
esophagogastric junction, or at the transformation zone of
the cervix.
Fourth, we found that cuboidal PECs may extend from the
proximal tubule onto Bowman’s capsule also in human pa-
tients. In glomerular disease models in male experimental
mice, the Bowman’s capsule is colonized by cuboidal PECs,
and we show data indicating that these cells transitioned into
iPECs and were activated preferentially and participated in
the formation of lesions. A higher prevalence of cuboidal
PECs in elderly and male patients has been described,43,44 and
these groups of patients also have a higher risk for chronic
kidney disease. In mice, virtually all FSGS models show
significantly more FSGS lesions in male than in female ani-
mals. The results of this study suggest that this novel aspect of
the microanatomy of the glomerulus could be associated with
the individual risk of a patient to develop FSGS lesions and
progression to CKD.
Finally, the results of this study suggest the epithelial
interface as potential origin for lesion formation, particularly
of the tip lesion at the tubular orifice.13 Previous studies
showed that mechanical stress or certain disease conditions
cause prolapse of visceral epithelial cells (podocytes) into the
proximal tubule to initiate formation of an adhesion (i.e.,
the tip lesion).45,46 This is in line with our observations that
podocytes are part of early sclerotic lesions.12,47 In the
present study, we show that more than 90% of the cells
within tip lesions expressed iPEC markers, suggesting that
iPECs (which are derived from proximal tubule cells)
contribute significantly to formation of this early lesion in
human patients.
The major limitation of this study is that our findings in
mice using lineage tracing to identify the origin of cells cannot
be translated directly to human patients for obvious technical
reasons. Furthermore, we have not yet succeeded to identify a
marker that labels iPECs in humans as well as in mice.
Another limitation of this study is that no more than 3
markers can be stained simultaneously, so that it cannot be
excluded that some cells are misclassified or go even unde-
tected. We have tried to reduce sampling bias and artifacts due
to tissue orientation as much as possible by analyzing suffi-
cient quantities of glomeruli. Nevertheless, we do believe that
the sum of the findings provides sufficient evidence to test our
hypothesis further that similar pathways are relevant in hu-
man patients.
In summary, we describe the unexpected role of 2 novel
PEC subgroups, which can be activated more easily than
classical flat PECs and which participate in formation of
glomerular lesions. Our findings support the notion that the
epithelial interface between flat and cuboidal PECs is an
unexpected novel hot spot of cellular activation and potential
origin of lesion formation, such as the tip lesion.
METHODS
Experimental animals
PEC-rtTA, Pax8-rtTA, LC1, R26R, and histone-eGFP transgenic lines
were on a FVB/N and Thy1.1 transgenic mice were on C57BL6/6J
genetic background and housed under standard specific pathogen–
free conditions.3,48 Most tissues from experimental animals were
used from previous studies as referenced. Animal procedures were
approved by the German Federal Authorities Landesamt für Natur,
Umwelt, und Verbraucherschutz (LANUV) Nordrhein-Westfalen or
as referenced in the text.
Doxycycline treatment
To activate transgene expression, animals received dox via the
drinking water ad libidum for a total of 7 or 14 days (1 mg/ml, 3%
sucrose, protected from light), which was exchanged every 2 days.
Subsequently, mice received tap water ad libidum for at least 10 days
(washout period).
Cell fate tracing and FSGS 5/6 nephrectomy–
deoxycorticosterone acetate–salt model in Pax8-rtTA mice
Eight-week-old quadruple transgenic PAX8-rtTA mice received dox
to induce labeling of intermediate and cuboidal PECs. For aging
experiments, the kidneys were analyzed after 3, 6, and 12 months.
For 5/6 nephrectomy, the mice were anesthetized deeply with
ketamine-xylazine (100 mg/ml ketanest and 20 mg/ml xylazine in
normal saline 0.9%; 0.1 ml/10 g of body weight) and a laparotomy
was made. The vasculature of the right kidney was removed and used
to verify the efficiency of the cellular labeling (t ¼ 0). The upper and
lower poles of the left kidney were excised and Gelastypt (Sanofi-
Aventis, Frankfurt, Germany) was used to stop bleeding. After 7 days,
a 50-mg pellet (released over 21 days) of deoxycorticosterone acetate
(DOCA; Innovative Research, Novi, MI) was implanted subcutane-
ously and 0.5% to 0.9% of NaCl was added to the drinking water.
=
Figure 3 | (continued) sections per mouse, unpaired t-test; ****P < 0.0001). (j) Analysis of the distribution of Ki-67 expression in PECs on
Bowman’s capsule in Thy1.1 mice 4 days after induction. PAS, periodic acid–Schiff; prom, promoter. To optimize viewing of this image, please
see the online version of this article at www.kidney-international.org.
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Figure 4 | Tubularized parietal epithelial cells (PECs) contribute to focal segmental glomerulosclerosis (FSGS) lesions in mice. (a) FSGS
tip lesion (arrow) in mice treated with adriamycin to induce FSGS (arrow, semithin sections, 2 weeks after injection31). Bar¼ 20 mm. (b) Schematic
of 5/6 nephrectomy (Nx)þ deoxycorticosterone acetate (DOCA)–salt model. (c) Exemplary images of FSGS lesions show green fluorescent protein
(GFP)þ cells within sclerotic lesions (arrows). Histone-eGFP is lost in some of the proximal tubular cells (arrows with tails; periodic acid–Schiff
[PAS]–stainings and enhanced GFP (eGFP) immunostaining in Pax8rtTA mice). (d) Quantification of eGFPþ (pos) FSGS lesion (*P¼ 0.0165, n¼ 5).
(e) b-galactosidase (ß-gal) staining of kidneys from Pax8-rtTA mice in the 5/6 nephrectomy and DOCA-salt FSGS model. (f) Presumptive FSGS
lesions in the early stage (left panel) or late stage (right panel; dashed circle marks sclerotic lesion); eGFPþ cells express src-suppressed C-kinase
(SSeCKS) de novo (arrows; cuboidal PECs, arrowhead). (g) Immunofluorescence of lotus tetragonolobus agglutinin (LTA) (green), eGFP (magenta),
and synaptopodin (synpo; red) shows loss of polarized expression of LTA in eGFPþ PECs within a proliferative lesion (left) and complete loss of
expression in eGFPþ cells on Bowman’s capsule (right panel). (h) Co-staining of ß-gal and LTA. LTA-negative ß-galþ PECs can be observed
(arrows), indicating that cuboidal PECs have lost their brush border in FSGS. Bars ¼ 50 mm. dox, doxycycline; IH, immunohistochemistry. To
optimize viewing of this image, please see the online version of this article at www.kidney-international.org.
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Figure 5 | Tip lesions contain keratin 7 (K7)D (pos) cells. Analysis of human (hum) glomerular (glom) tip lesions, adhesions, or not
otherwise specified (NOS) sclerotic lesions in transplant patients with early recurrence of focal segmental glomerulosclerosis (FSGS). (a) Serial
sections stained with periodic acid–Schiff (PAS) or immunofluorescent anti-K7 (red) and anti-CD44 (green). Cells within tip lesions were
K7þ (arrowheads) but not always CD44þ. K7þ cells were observed also on Bowman’s capsule (presumptive iPECs, arrows with tails). CD44
was expressed by tubular cells in the scattered tubular cell phenotype and inflammatory cells. Additional autofluorescent staining comes
from erythrocytes within the glomerular tuft (green). Asterisks indicate the tubular outlet. (b,c) Frequency of K7þ lesions in FSGS. Exemplary
images of a K7-negative (neg) (left panel) or pos (right panel) glomerular adhesion (arrowheads), visualized by the global PEC marker
annexin A3 (ANXA3). (c) ANXA3þ tip lesions contained K7þ cells in 89.2% in 23 patients diagnosed with the tip variant of
FSGS (*P < 0.001, ****P < 0.0001, n ¼ 45 glomeruli). This difference was less pronounced in other adhesions away from the tubular
outlet or FSGS lesions not otherwise specified. Bar ¼ 100 mm. NS, not significant. To optimize viewing of this image, please see the online
version of this article at www.kidney-international.org.
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During this period, general well-being, body weight, and proteinuria
were closely monitored. The remnant left kidney was recovered and
processed for histology. To analyze nephrotoxic nephritis, mice were
analyzed 8 days after injection of anti-glomerular basement mem-
brane serum (see Smeets et al.4).
Antibody-mediated (“accelerated”) Thy-1.1 model
Injection of anti–Thy-1.1 antibodies accelerates the development of
proteinuria and FSGS in Thy-1.1 transgenic mice, resulting in an
acute and massive proteinuria and dose-dependent development of
collapsing FSGS lesions within 7 days. Thy-1.1 mice received an i.v.
injection with 1 mg of anti–Thy-1.1 monoclonal antibody (19XE5
[clone 19XE5]) in 0.1 ml of 0.9% saline solution. Kidney samples
were collected 5 days after the injection (n ¼ 4).
Perfusion fixation
Mice were anesthetized (ketamine-rompun). The kidney(s) were
perfused via the left heart ventricle with 3% paraformaldehyde in
phosphate-buffered saline (pH 7.6) for 3 minutes. Pieces of the
kidney(s) were snap-frozen in liquid nitrogen or (post-)fixed in 3%
buffered formalin and embedded in paraffin.
Light microscopy
For light microscopy, the 4% buffered formalin-fixed kidney frag-
ment were dehydrated and embedded in paraffin. Four-micrometer
paraffin sections were stained with PAS. To obtain the percentage of
glomeruli-containing lesions, at least 50 glomeruli per mouse were
evaluated for the presence of hypertrophy and hyperplasia of the
glomerular epithelium, adhesions, sclerosis, or hyalinosis. ß-Gal
activity was detected using enzymatic b-galactosidase staining as
described elsewhere.3
Immunofluorescence. Immunofluorescence staining was per-
formed on 2-mm paraffin-embedded sections. CD44 (R&D Systems,
Minneapolis, MN), synaptopodin (P-19; Santa Cruz Biotechnology,
Dallas, TX), cyclin-D1 (ab16663; Abcam, Cambridge, UK), Ki-67
(ab16667-500; Abcam), SSeCKS (homemade by Dr. Gelman), K19
(ab15463; Abcam), K7 (ab9021; Abcam), and EGFP (ab13970;
Abcam) immunostaining were performed as described previously.12
The following secondary antibodies were used: donkey anti-rabbit,
mouse, chicken, or rat Alexa Fluor 488, Alexa Fluor 549, or Alexa
Fluor 647 (Dianova, Hamburg, Germany). The nuclei were stained
using Hoechst 33342 (Sigma-Aldrich, St. Louis, MO). Sections were
evaluated with a Keyence BZ-9000 Microscope using BZ-II
Analyzing software (Keyence Corporation, Osaka, Japan). Analysis
of distributions of EGFP, cyclin-D1, and Ki-67 on Bowman’s capsule
was performed on sections counterstained with Hoechst and
Fluorescein-labeled Lotus Tetragonolobus Lectin (LTL-FITC; Vector
Laboratories, Burlingame, CA). At least in 25 glomeruli per kidney
section, the location in relation to LTL-FITC of EGFP/cyclin-D1/Ki-
67 was analyzed.
Immunohistochemistry. Immunohistochemistry was per-
formed on 4-mm paraffin-embedded or 3% paraformaldehyde-fixed
cryosections. CD44 immunostaining were combined with a PAS
staining. Sections were blocked with Avidin/Biotin Blocking Kit
(Vector Laboratories) and 3% H2O2. The sections were subjected to
microwave antigen retrieval in Antigen Unmasking Solution (Vector
Laboratories) followed by incubation with the primary (anti-CD44)
and secondary antibodies. As secondary antibodies, we used bio-
tinylated goat anti-rat (Vector Laboratories). Detection was carried
Figure 6 | Schematic summary and proposed pathways of early lesion formation. (a) Parietal epithelial cell (PEC) subgroups
are highlighted in color. Upon glomerular injury, podocytes are injured and partially lost. Some prolapse toward the tubular outlet
(black nucleus) and come into contact with intermediate PECs (iPECs) at the epithelial interface. iPECs migrate onto the glomerular tuft and
deposit their matrix (tip lesion). (b) In male mice and in some human patients, proximal tubule cells extend onto Bowman’s capsule (BC) and
are known as cuboidal PECs (cPECs). In glomerular disease, cellular activation results in proliferation of iPECs. In addition, cPECs may
transition into the intermediate phenotype. iPECs form adhesions that are not immediately at the tubular orifice. As demonstrated
previously, flat PECs (fPECs) may also become activated and may proliferate and participate in lesion formation (not shown in this
schematic). FSGS, focal segmental glomerulosclerosis.
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out with Vectastain ABC kit (Vector Laboratories) with the use of
peroxidase as label and 3,3-diaminobenzidine as substrate and nickel
chloride enhancement. Subsequent to the immunostaining, a PAS
staining was performed.
Electron microscopy
Small pieces of renal cortex were fixed in Karnovsky’s fixative,
postfixed in 1% osmium tetroxide, dehydrated in ethanol and pro-
pylene oxide, and embedded in Epon resin (Serva, Heidelberg,
Germany). Ultrathin sections were counterstained with 0.5% uranyl
acetate and 1% lead citrate (both EMS, Munich, Germany) and
examined with a Zeiss Leo 906 transmission electron microscope
(Carl Zeiss, Oberkochen, Germany) at 60 kV as described
previously.49
Studies involving human kidney tissue or biopsies
The collection of human samples was approved by the local ethics
committee of the Medical Faculty in Nijmegen, The Netherlands
(2018-4086), the Vanderbilt University Medical Center, Nashville,
Tennessee, and Aachen University (EK 221/16). Formalin-fixed
paraffin-embedded sections of renal biopsies from 23 subjects with
FSGS classified as tip variant according to the Columbia classification
were included (Supplementary Table S1). In addition, unaffected
renal tissue from patients with renal carcinoma, provided by the
Eschweiler-Aachen Biobank (Germany), were used as control tissues.
For analysis of cuboidal PECs in humans. Normal renal tissue from
10 male and female patients with renal carcinoma, provided by the
Eschweiler-Aachen Biobank, were used for analysis (Supplementary
Table S2). All sections were evaluated with a Keyence BZ-9000 Mi-
croscope using BZ-II Analyzing software (Keyence Corporation).
Statistics
All values are expressed as means  SD. For comparison of 2 groups,
t-test was used. Comparison of several groups was performed using
analysis of variance; post hoc Bonferroni correction was used for
multiple comparisons. All tests were 2-tailed and statistical signifi-
cance was defined as P < 0.05.
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SUPPLEMENTARY MATERIAL
Figure S1. Scattered tubular cell markers and parietal epithelial
subpopulations. Immunofluorescent staining for keratin 7 (K7), K19,
hepatocyte nuclear factor-4 (HNF4a) and lotus tetragonolobus
agglutinin (LTA). (A) HNF4a marks proximal tubular cells (inset). Note
that K7þ cells were located in conjunction to HNF4a at the tubular-
glomerular junction. (B) HNF4aþ cells could be detected on Bow-
man’s capsule. Note that K7þ cells were located in conjunction to
HNF4aþ cells. (C) K19þ cells can be detected in direct conjunction to
LTAþ tubular cells (arrow). Bars ¼ 100 mm.
Figure S2. Analysis of CD24/glycosylated CD133 (glyCD133) on
Bowman’s capsule. (A,B) Schematic of the nomenclature. (B)
According to previous reports, a graded expression of progenitor
markers into podocyte markers (PDX) indicated continuous
podocyte regeneration. (C,D) Representative immunofluorescent co-
stainings of podocalyxin (podocytes), claudin-1 (fPECs), and either
CD24 or glyCD133. Bar ¼ 100 mm. (E) Expression of glyCD133 and
claudin-1 as percentage of the circumference of Bowman’s capsule
in normal human kidney (total of 238 glomeruli in 6 different ne-
phrectomy specimens). PODs, podocytes; CD133þCD24þPDX
PECs, presumptive localization of renal progenitors (red circle), cPEC;
cuboidal PEC; fPEC, focal PEC; PDX, podocalyxin; PEC, parietal
epithelial cell.
Figure S3. Parietal epithelial cell (PEC) subpopulations in mice
and humans. (A) Immunofluorescent staining for src-suppressed
C-kinase (SSeCKS, which are focal PECs), lotus tetragonolobus
agglutinin (LTA, which are cuboidal PECs), and synaptopodin
(podocytes). (B) Electron microscopy (EM) overview of Bowman’s
capsule in mice. Inset marks image selection for Figure 1l.
Cuboidal PECs form a brush border at the apical membrane
(arrows). Focal PECs are marked with arrowheads. (C) Normal
human kidney section from tumor nephrectomies stained with
LTA (cuboidal PECs). Note that 3 glomeruli show LTAþ cells on
Bowman’s capsule (arrows) close to the tubular pole (arrows with
tails). Glomeruli are marked by asterisks. Bars ¼ 100 mm.
Figure S4. (A) In the PEC-rtTA mouse after a pulse chase period of 3
months, the histone-eGFP metabolic label persisted preferentially in
intermediate parietal epithelial cells (iPECs) (arrows). (B) Analysis of
enhanced green fluorescent protein (EGFP)þ nuclei on Bowman’s
capsule in aged PEC-rtTA mice (n ¼ 5, analysis of variance, P < 0.001).
(C) In Pax8-rtTA mice subjected to 5/6 nephrectomy and deoxy-
corticosterone acetate (DOCA)–salt treatment to induce focal
segmental glomerulosclerosis (FSGS) lesions, CD44 was expressed in
the EGFPþ presumptive iPECs (arrowhead). In the example shown,
the adjacent cuboidal PEC has also retained its GFP-histone labeling
but does not express activation marker CD44 (arrow). Labeling within
tubular cells is marked by arrows with tails. Bars ¼ 50 mm. LTA, lotus
tetragonolobus agglutinin.
Figure S5. Keratin 7 (K7)þ cells (presumptive intermediate parietal
epithelial cells) within focal segmental glomerulosclerosis lesions. (A)
Examples of a tip lesion with little K7 expression (arrowheads). (B)
Example of a lesion not otherwise specified (NOS) containing a
mixture of K7þ (arrowheads) or K7-negative (arrows) adhesions and
lesions. Immunofluorescent co-stainings for the global parietal
epithelial cell marker annexin A3 (ANXA3) and K7. Bars ¼ 100 mm.
Table S1. Demographics of patients classified with focal segmental
glomerulosclerosis (FSGS).
Table S2. Demographics of patients with kidney tumor
nephrectomies.
Supplementary material is linked to the online version of that paper
at www.kidney-international.org.
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